Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Colgate Duraphat 5000ppm fluoride toothpaste
0905030G0BPACBY
|
Colgate Duraphat | Sodium fluoride | Nutrition and Blood | 21,913 |
|
Sevelamer 800mg tablets
0905022S0AAABAB
|
Sevelamer | Sevelamer | Nutrition and Blood | 21,894 |
|
Folic acid 2.5mg/5ml oral solution sugar free
0901020G0AACICI
|
Folic acid | Folic acid | Nutrition and Blood | 21,834 |
|
Sanatogen Complete A-Z tablets
091200000BFXGFT
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | 21,744 |
|
Calcichew 500mg chewable tablets
0905011D0BCAAAJ
|
Calcichew | Calcium carbonate | Nutrition and Blood | 21,589 |
|
Resource ThickenUp Clear powder
0913161A0BEAAAA
|
Resource powder thickener - gum based | Powder thickener - gum based (0913161) | Nutrition and Blood | 21,233 |
|
Pyridoxine 50mg tablets
0906024N0AAAIAI
|
Pyridoxine hydrochloride | Pyridoxine hydrochloride | Nutrition and Blood | 20,882 |
|
InVita D3 25,000units/1ml oral solution
0906040G0DFAADH
|
InVita D3 | Colecalciferol | Nutrition and Blood | 20,806 |
|
Forceval Soluble tablets
090607000BBLCA0
|
Proprietary compound preparation BNF 0906070 | Other multivitamin preparations | Nutrition and Blood | 20,079 |
|
Cinacalcet 30mg tablets
0905012I0AAAAAA
|
Cinacalcet hydrochloride | Cinacalcet hydrochloride | Nutrition and Blood | 19,817 |
|
Ferrous fumarate 140mg/5ml oral solution
0901011F0AAACAC
|
Ferrous fumarate | Ferrous fumarate | Nutrition and Blood | 19,699 |
|
Sodium chloride 600mg modified-release tablets
0902012L0AAAJAJ
|
Sodium chloride (Systemic) | Sodium chloride | Nutrition and Blood | 19,183 |
|
Natecal D3 600mg/400unit chewable tablets
0906040G0BUAABY
|
Natecal D3 | Colecalciferol | Nutrition and Blood | 18,675 |
|
CyanocoMinn 50microgram tablets
0901020D0BIABAE
|
CyanocoMinn | Cyanocobalamin | Nutrition and Blood | 17,572 |
|
Fortijuce liquid (5 flavours)
0913011M0BEABAA
|
Fortijuce ready to serve 1.5 kcal/ml juice style | Ready to serve 1.5 kcal/ml juice style (0913011) | Nutrition and Blood | 17,429 |
|
Aptamil Pepti 2 powder
0913101A0BEAAAD
|
Aptamil Pepti 2 powder extensively hydrolysed formula | Powder extensively hydrolysed formula (0913101) | Nutrition and Blood | 17,191 |
|
Neocate LCP powder
0913107A0BDAAAB
|
Neocate powder amino acid formula (0913107) | Powder amino acid formula (0913107) | Nutrition and Blood | 17,149 |
|
Stexerol-D3 25,000unit tablets
0906040G0DHABDK
|
Stexerol-D3 | Colecalciferol | Nutrition and Blood | 15,666 |
|
Colecalciferol 3,200unit capsules
0906040G0AADFDF
|
Colecalciferol | Colecalciferol | Nutrition and Blood | 15,126 |
|
Colecalciferol 50,000unit capsules
0906040G0AAEQEQ
|
Colecalciferol | Colecalciferol | Nutrition and Blood | 14,975 |
|
Magnesium aspartate (magnesium 10mmol) oral powder sachets
0905013A0AAAHAH
|
Magnesium aspartate | Magnesium aspartate | Nutrition and Blood | 14,547 |
|
Valupak Multivitamin and Mineral One A Day tablets
091000000BBPPBU
|
Proprietary compound preparation BNF 0910000 | Other compound vitamin/mineral formulation preparations | Nutrition and Blood | 14,297 |
|
Lift Fast Acting Glucose Shot liquid (4 flavours)
0913541B0BBAAAA
|
Lift liquid OTC glucose for diabetic hypo treatment | Liquid OTC glucose for diabetic hypo treatment (0913541) | Nutrition and Blood | 13,519 |
|
Aymes Shake powder 57g sachets banana
0913011C0BBAAAH
|
Aymes powder 1.6 kcal/ml milkshake | Powder 1.6 kcal/ml milkshake (0913011) | Nutrition and Blood | 13,517 |
|
Nutramigen 1 with LGG powder
0913101A0BGAAAE
|
Nutramigen 1 powder extensively hydrolysed formula | Powder extensively hydrolysed formula (0913101) | Nutrition and Blood | 13,275 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.